Categories
Latest Industry Intelligence
Download our new whitepaper ‘From bench to billions: A guide to facilitating scale-up of adherent [...]
Download our latest eBook ‘Technology in the lab: what’s enabling drug discovery?’ sponsored by Analytik [...]
This is the latest episode of the free narrated DDW podcast, “CROs and targeted protein degradation offer an exciting future”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “CROs: Drug discovery expertise on hand” and “Why the emergence of targeted protein degradation is so exciting”. […]
DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. The Market After over two years of the Covid-19 pandemic, 2022 year was somewhat of a return to normal for both the world at […]
Cell and gene therapies (CGT) are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future. Join this free webinar, hosted by DDW and supported by BPS Bioscience and Benchling, to learn about the biggest challenges and opportunities facing the cell and […]
Cell and gene therapies are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future. In this free webinar on February 17, 2023 you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy Catapult, […]
Download this exclusive cell and gene therapy guide to learn about: The successes of cell and gene therapies plus the biggest questions facing the sector Expert views on the challenges and opportunities for cell and gene therapies in 2023 Understanding future road maps of cell and gene therapies Why there are two sides to the […]
DDW has published the first of its new Guide Series, Where is the global innovation and the opportunity in cell and gene therapy? It is sponsored by Astrea BioSeparations and Benchling. In this free, exclusive guide, you will learn more about: The successes of cell and gene therapies plus the biggest questions facing the sector […]
The DDW SLAS2023 supplement is out now. Ahead of SLAS2023 which takes place 25 February – 1 March, the supplement explores the innovations and technologies that are driving drug discovery and laboratory research. The DDW SLAS2023 supplement looks towards the event and covers key topics including: Acquiring deeper insights and acceleration with AI Connecting lab […]
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Clinical trials have led our news section this week, with positive results announced from several Phase I and II studies. There was good […]
Kevin Hemphill, R&D Manager at PerkinElmer’s Horizon Discovery explores how base editing has emerged as an attractive gene editing option for researchers wanting to develop stem cell-based therapies. Increasing interest in CRISPR-Cas gene editing systems over recent years has delivered innovative developments in precision genome engineering technologies, holding enormous potential for applications across the healthcare […]
This paid-for advertorial by Aurora Microplates appeared in DDW Volume 24 – Issue 1, Winter 2022/2023 Aurora Microplates is focused on making the highest quality, highest performing microplates available. The company uses the best materials, the cleanest and most precise moulding operations and facilities to deliver high performance microplates in a timely fashion. Pure […]